Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pulmonary Hypertension

Free Subscription Articles published in Circ Res Retrieve available abstracts of 38 articles: HTML format

Single Articles

April 2024
1. CHU X, Kheirollahi V, Lingampally A, Chelladurai P, et al
   GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary Hypertension.
   Circ Res. 2024 Apr 19. doi: 10.1161/CIRCRESAHA.123.323736.
   PubMed     Abstract available
   
   
   March 2024
2. COSTE B, Delmas P
   PIEZO Ion Channels in Cardiovascular Functions and Diseases.
   Circ Res. 2024;134:572-591.
   PubMed     Abstract available
   
   
   February 2024
3. MURUGESAN P, Zhang Y, Huang Y, Chengong Zong N, et al
   Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR.
   Circ Res. 2024 Feb 1. doi: 10.1161/CIRCRESAHA.123.323090.
   PubMed     Abstract available
   
   
   December 2023
4. KNIGHT H, Abis G, Kaur M, Green HLH, et al
   Cyclin D-CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation.
   Circ Res. 2023;133:966-988.
   PubMed     Abstract available
   
   
   November 2023
5. DAI Z, Thorp EB
   New Way to Study Pulmonary Hypertension in HFpEF.
   Circ Res. 2023;133:899-901.
   PubMed    
   
   
   
6. AGRAWAL V, Kropski JA, Gokey JJ, Kobeck E, et al
   Myeloid Cell Derived IL1beta Contributes to Pulmonary Hypertension in HFpEF.
   Circ Res. 2023;133:885-898.
   PubMed     Abstract available
   
   
   September 2023
7. RANASINGHE ADCU, Holohan M, Borger KM, Donahue DL, et al
   Altered Smooth Muscle Cell Histone Acetylome by the SPHK2/S1P Axis Promotes Pulmonary Hypertension.
   Circ Res. 2023 Sep 12. doi: 10.1161/CIRCRESAHA.123.322740.
   PubMed     Abstract available
   
   
   August 2023
8. ZHOU X, Jiang Y, Wang Y, Fan L, et al
   Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension.
   Circ Res. 2023 Aug 17. doi: 10.1161/CIRCRESAHA.122.321200.
   PubMed     Abstract available
   
   
   May 2023
9. GONCHAROVA EA, Kudryashova TV, de Jesus Perez VA, Rafikova O, et al
   UnWNTing the Heart: Targeting WNT Signaling in Pulmonary Arterial Hypertension.
   Circ Res. 2023;132:1486-1488.
   PubMed    
   
   
   
10. NAYAKANTI SR, Friedrich A, Sarode P, Jafari L, et al
    Targeting Wnt-ss-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling.
    Circ Res. 2023;132:1468-1485.
    PubMed     Abstract available
    
    
    February 2023
11. WANG L, Moonen JR, Cao A, Isobe S, et al
    Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
    Circ Res. 2023 Feb 6. doi: 10.1161/CIRCRESAHA.121.320541.
    PubMed     Abstract available
    
    
    
12. PI H, Xia L, Ralph DD, Rayner SG, et al
    Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.
    Circ Res. 2023;132:254-266.
    PubMed     Abstract available
    
    
    January 2023
13. CUTHBERTSON I, Morrell NW, Caruso P
    BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension.
    Circ Res. 2023;132:109-126.
    PubMed     Abstract available
    
    
    October 2022
14. NANDULA PS, Shah SD, Park CS, Kim SH, et al
    Sox17 Deficiency Promotes Pulmonary Arterial Hypertension via HGF/c-Met Signaling.
    Circ Res. 2022;131:792-806.
    PubMed     Abstract available
    
    
    
15. WANG C, Xing Y, Zhang J, He M, et al
    MED1 Regulates BMP/TGF-beta in Endothelium: Implication for Pulmonary Hypertension.
    Circ Res. 2022 Oct 14. doi: 10.1161/CIRCRESAHA.122.321532.
    PubMed     Abstract available
    
    
    
16. KUDRYASHOVA TV, Goncharova EA
    MonOrail to Cure? Targeting Orai1 to Reverse Pulmonary Arterial Hypertension.
    Circ Res. 2022;131:728-730.
    PubMed    
    
    
    
17. MASSON B, Le Ribeuz H, Sabourin J, Laubry L, et al
    Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension.
    Circ Res. 2022;131:e102-e119.
    PubMed     Abstract available
    
    
    April 2022
18. HUSTON JH, Shah SJ
    Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
    Circ Res. 2022;130:1382-1403.
    PubMed     Abstract available
    
    
    
19. RHODES CJ, Sweatt AJ, Maron BA
    Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension.
    Circ Res. 2022;130:1423-1444.
    PubMed     Abstract available
    
    
    
20. SINGH N, Dorfmuller P, Shlobin OA, Ventetuolo CE, et al
    Group 3 Pulmonary Hypertension: From Bench to Bedside.
    Circ Res. 2022;130:1404-1422.
    PubMed     Abstract available
    
    
    
21. BOUCHERAT O, Agrawal V, Lawrie A, Bonnet S, et al
    The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.
    Circ Res. 2022;130:1466-1486.
    PubMed     Abstract available
    
    
    
22. ALDRED MA, Morrell NW, Guignabert C
    New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis.
    Circ Res. 2022;130:1365-1381.
    PubMed     Abstract available
    
    
    
23. ALENEZI F, Covington TA, Mukherjee M, Mathai SC, et al
    Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.
    Circ Res. 2022;130:1445-1465.
    PubMed     Abstract available
    
    
    March 2022
24. CULLEY MK, Chan SY
    Endothelial Senescence: A New Age in Pulmonary Hypertension.
    Circ Res. 2022;130:928-941.
    PubMed     Abstract available
    
    
    
25. KUDRYASHOVA TV, Dabral S, Nayakanti S, Ray A, et al
    Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
    Circ Res. 2022;130:760-778.
    PubMed     Abstract available
    
    
    April 2021
26. MONTEIRO JP, Rodor J, Caudrillier A, Scanlon JP, et al
    MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular Disease.
    Circ Res. 2021;128:1173-1190.
    PubMed     Abstract available
    
    
    December 2020
27. HENNIGS JK, Cao A, Li CG, Shi M, et al
    PPARgamma-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
    Circ Res. 2020 Dec 16. doi: 10.1161/CIRCRESAHA.119.316339.
    PubMed     Abstract available
    
    
    October 2020
28. YANG P, Yu PB
    Periostin: A Novel Integrator of Hypoxic Signaling in Pulmonary Hypertension.
    Circ Res. 2020;127:1153-1155.
    PubMed    
    
    
    September 2020
29. JIA D, Bai P, Wan N, Liu J, et al
    Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages.
    Circ Res. 2020 Sep 11. doi: 10.1161/CIRCRESAHA.120.316784.
    PubMed     Abstract available
    
    
    August 2020
30. LEOPOLD JA
    Endocrine Delivery of MicroRNA-210: A Trusted Traveler That Mediates Pulmonary Hypertension.
    Circ Res. 2020;127:693-695.
    PubMed    
    
    
    June 2020
31. ZHAO J, Florentin J, Tai YY, Torrino S, et al
    Long Range Endocrine Delivery of Circulating miR-210 to Endothelium Promotes Pulmonary Hypertension.
    Circ Res. 2020 Jun 4. doi: 10.1161/CIRCRESAHA.119.316398.
    PubMed     Abstract available
    
    
    November 2019
32. BOCHENEK ML, Leidinger C, Rosinus NS, Gogiraju R, et al
    Activated Endothelial TGFbeta1 Signaling Promotes Venous Thrombus Non-Resolution in Mice Via Endothelin-1: Potential Role for Chronic Thromboembolic Pulmonary Hypertension.
    Circ Res. 2019 Nov 21. doi: 10.1161/CIRCRESAHA.119.315259.
    PubMed     Abstract available
    
    
    June 2019
33. CALVIER L, Boucher P, Herz J, Hansmann G, et al
    LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARgamma Activation.
    Circ Res. 2019;124:1778-1785.
    PubMed     Abstract available
    
    
    March 2019
34. LEOPOLD JA, Maron BA
    Precision Medicine in Pulmonary Arterial Hypertension.
    Circ Res. 2019;124:832-833.
    PubMed    
    
    
    
35. ORMISTON ML, Godoy RS, Chaudhary KR, Stewart DJ, et al
    The Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension.
    Circ Res. 2019;124:822-824.
    PubMed    
    
    
    
36. SWEATT AJ, Hedlin HK, Balasubramanian V, Hsi A, et al
    Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.
    Circ Res. 2019;124:904-919.
    PubMed     Abstract available
    
    
    January 2019
37. MIYAGAWA K, Shi M, Chen PI, Hennigs JK, et al
    Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.
    Circ Res. 2019;124:211-224.
    PubMed     Abstract available
    
    
    
38. YANG P, Yu PB
    In Search of the Second Hit in Pulmonary Arterial Hypertension.
    Circ Res. 2019;124:6-8.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.